Innovative Collaboration Between Biocare Medical and Proteintech Emerges to Transform Antibody Technologies Biocare Medical and Proteintech have partnered to enhance next-gen antibody technologies for modern diagnostics. This collaboration aims to address evolving pathology needs through advanced solutions.

Innovative Collaboration Between Biocare Medical and Proteintech Emerges to Transform Antibody Technologies #USA #San_Francisco #Biocare_Medical #Antibody_Technology #Proteintech

Harbour BioMed Unveils Impressive Growth in 2025 Interim Results with Focus on Innovation Harbour BioMed showcases remarkable growth in 2025 with significant revenue rises and an expansive pipeline, emphasizing innovative treatments in immunology and oncology.

Harbour BioMed Unveils Impressive Growth in 2025 Interim Results with Focus on Innovation #China #Shanghai #Harbour_BioMed #Immunology #Antibody_Technology

Harbour BioMed and AstraZeneca Forge Alliance for Next-Gen Therapeutic Antibodies Harbour BioMed partners with AstraZeneca to develop next-generation multi-specific antibodies, aiming to reshape treatments for immunology and oncology with innovative technologies and strategic investment.

Harbour BioMed and AstraZeneca Forge Alliance for Next-Gen Therapeutic Antibodies #China #Beijing #AstraZeneca #Harbour_BioMed #Antibody_Technology